Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu
2021-08-06
SCID: 54.1/zvumjnr9
Publication Details
Publication Date
2021-08-06
Journal
Publisher
ISSN
Access Type
Author Information
Download PDF